The Plus SideZ: A GLP-1 Guide to Metabolic Health

Linktree - our favorite links ( https://linktr.ee/dinosaurmonkeyfarts ) NEW: Need GLP-1 Care? Join me at Belle ! Use Podcast at checkout to save! https://link.joinbelle.com/podcast NEW : Cozy Butter GLP-1 Community ! Join Free ( https://cozybutter.com/ ) https://cozybutter.com/ A GLP-1 community where support isn’t at the mercy of the algorithm. Live GLP-1 support groups Live support groups and social events Health coaching and expert Q&As Cooking, movement, and stress-management classes GLP-1 tools and guidance (water, protein, side effect management, etc.) A dedicated community beyond the algorithm Book at 1 on 1 with Kim ( https://calendly.com/theplussidez/kim... ) The World Has More GLP-1s but Who Can Afford Them? Part 2 This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication. Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world. In Part 2, we discuss: • Managing daily life and side effects on GLP-1 medication • Why weight loss slows and plateaus happen • How the body’s set point may affect weight • What GLP-1 maintenance really means • Balancing continued weight loss with stabilization • Adjusting treatment for long-term care • What Ireland could learn from the U.S. rollout of GLP-1 medications Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience navigating GLP-1 side effects, plateaus, maintenance and long-term treatment. CONNECT WITH OUR GUESTS Dr. Michael “Mick” Crotty My Best Weight https://www.mybestweight.ie/ Instagram https://www.instagram.com/mybestweight.ie/ LinkedIn https://ie.linkedin.com/in/drmichaelcrotty Belinda Hogan Instagram https://www.instagram.com/mid.life.insights/ The Dose with Paddy and Belinda https://linktr.ee/TheDosePodcast SOURCES Oral Wegovy launches in Germany https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/ Hims & Hers expands its GLP-1 services into Australia https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/ 600,000 people sign up for the Medicare obesity drug program https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/ Employer GLP-1 coverage fell in 2026 https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/ PepsiCo and other employers cut GLP-1 coverage https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790 Medicare enrollment data https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

I have exciting news! After 3 years of this podcast, interviewing obesity medicine experts and hearing from tens of thousands of you, I kept seeing the same gap between getting the prescription and the support we need to actually get to whatever our goal is. So my friend, fellow obesity care advocate and now partner, Amanda Bonello and I decided to do something about it. We built the Cozy Butter GLP-1 Community. It’s a place for live support, expert Q&As, health coaches, cooking classes, tools and resources built from cited sources, and most importantly, real connection with people who understand this journey. You can join us for free right now at CozyButter.com . Amanda and I built this for you because we believe you deserve better. And you shouldn’t have to figure this out alone. Welcome to The Butter Way . 🧈 Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree - our favorite links NEW : Cozy Butter GLP-1 Community! Join Free https://cozybutter.com/ A GLP-1 community where support isn’t at the mercy of the algorithm. - Live GLP-1 support groups - Live support groups and social events - Health coaching and expert Q&As - Cooking, movement, and stress-management classes - Practical GLP-1 tools and guidance (water, protein, side effect management, etc.) - A dedicated community beyond the algorithm Book at 1 on 1 with Kim ______________________________________________________________________ The World Has More GLP-1s but Who Can Afford Them? Part 1 This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication. Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world. In Part 1, we discuss: • How fat functions in the body and why it is considered an organ • GLP-1 access, costs and treatment criteria in Ireland • Which obesity medications were available in Ireland • Differences between obesity care in Ireland and the United States • Weight bias in healthcare and society • Why obesity requires medical care, not more blame Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience using GLP-1 medication and navigating obesity care. CONNECT WITH OUR GUESTS Dr. Michael “Mick” Crotty My Best Weight https://www.mybestweight.ie/ Instagram https://www.instagram.com/mybestweight.ie/ LinkedIn https://ie.linkedin.com/in/drmichaelcrotty Belinda Hogan Instagram https://www.instagram.com/mid.life.insights/ The Dose with Paddy and Belinda https://linktr.ee/TheDosePodcast SOURCES Oral Wegovy launches in Germany https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/ Hims & Hers expands its GLP-1 services into Australia https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/ 600,000 people sign up for the Medicare obesity drug program https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/ Employer GLP-1 coverage fell in 2026 https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/ PepsiCo and other employers cut GLP-1 coverage https://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790 Medicare enrollment data https://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment ______________________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! The Podcast Promo Ad Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree for Community Resources https://linktr.ee/theplussidez Join our free GLP-1 Community! www.CozyButter.com Book a 1 on 1 Session with Kim - Code PLUS10 to save https://calendly.com/theplussidez/kim ______________________________________________________________________ GLP-1 vs. Big Food: Is the Food Industry Trying to Outsmart the Medications? What role has the food industry played in obesity, and how are GLP-1 medications changing what companies put on grocery store shelves? Food scientist Liam Kincaid joins Kim and Bear to take us inside the science and psychology of food. They explore what makes certain foods easy to overeat, why novelty keeps us coming back, and whether sugar, preservatives, or any single ingredient deserves the blame. Liam also explains why the grams of protein on a label do not tell the whole story, how to identify higher-quality protein sources, and why adding protein does not automatically make something “GLP-1 friendly.” Plus, they discuss how GLP-1s can change cravings and food preferences, whether the food industry is trying to work around the medications’ effects, and why fiber, savory flavors, and entirely new products may shape the future of food. This is an honest conversation about food, biology, access, and why people living with obesity deserve better than blame or another shiny label. Follow Liam: LinkedIn https://www.linkedin.com/in/liam-kincaid-ba498022a TikTok https://www.tiktok.com/t/ZP87VgedS/ APOTHIKS Food Consulting https://www.apothiks.com _____________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! The Podcast Promo Ad Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Join a Paid Support Group - Coupon Code PLUS30 Book It Here *This episode discusses eating disorders, disordered eating, substance use, body image, and other sensitive topics. Please take care of yourself while listening. In Part 2 of Kat's conversation with Nanette Adams, MEd, LPC, LMHC, they have a candid discussion about eating disorders, substance use, and obesity care from both a professional and lived-experience perspective. Nanette is a therapist specializing in obesity and eating disorders, an obesity advocate, and a person living with obesity who has experienced both bariatric surgery and GLP-1 treatment herself. Together, she and Kat explore how our relationships with food, movement, our bodies and other coping behaviors can change throughout obesity treatment, and why eating disorders can be particularly difficult to recognize when weight loss is being celebrated. You'll leave with a better understanding of how eating disorders and substance use can intersect with obesity treatment, why they can be missed in higher-weight bodies, and when you or someone you love may need additional support. Connect with Nanette: Weighted Wisdoms: https://weightedwisdoms.com Substack: https://weightedwisdoms.substack.com Instagram: @nanetteadamslpc TikTok: @weightedwisdoms Facebook: Weighted Wisdoms Support & Resources If you or someone you love is struggling with an eating disorder, disordered eating, substance use or mental health, support is available. National Alliance for Eating Disorders Therapist-staffed helpline: 866-662-1235 Monday–Friday, 9 a.m.–7 p.m. ET Find treatment and eating disorder support: https://www.findedhelp.com/ https://www.allianceforeatingdisorders.com/ SAMHSA National Helpline 1-800-662-HELP (4357) Free, confidential treatment referral and information, available 24/7. https://www.samhsa.gov/find-help/helplines https://findtreatment.gov/ If you are in crisis: Call or text 988 for the 988 Suicide & Crisis Lifeline. If you are experiencing a medical emergency or are in immediate danger, call 911. Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree for Community Resources NEW From The Plus SideZ! Need extra help on your GLP-1 Journey? We have options! Live Patient Group with Kim Sign up here : Save with Code PLUS10 One-on-One Session with Kim Schedule here : Save with Code PLUS15 _____________________________________________________________ GLP-1 & Weight Regain: Why We Blame Ourselves When weight regain happens, most people ask, "What am I doing wrong?" Weight regain can happen during GLP-1 treatment, after bariatric surgery, or years into an obesity journey. For many, the first response is self-blame. Licensed therapist, obesity advocate, and person living with the disease of obesity, Nanette Adams, shares her personal journey while exploring why obesity is a chronic disease, how treatment often evolves over time, and the emotional toll of stalls, plateaus, and weight regain. We discuss therapy, shame, self-compassion, and why long-term support matters. About Our Guest Nanette Adams, LPC, LMHC is a licensed therapist, obesity advocate, and person living with the disease of obesity. Through her platform, Weighted Wisdoms, she combines professional expertise with lived experience to help people better understand obesity, weight stigma, and the emotional side of long-term treatment. Connect with Nanette Website https://weightedwisdoms.com Substack https://weightedwisdoms.substack.com Instagram https://www.instagram.com/nanetteadamslpc/ TikTok https://www.tiktok.com/@weightedwisdoms Facebook http://www.facebook.com/weightedwisdoms _____________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Sign Up for Our Plus SideZ GLP-1 Patient Support Group - $50 https://forms.gle/aHvZiiBXFr6q7NQY7 Linktree Our Favorite Things https://linktr.ee/theplussidez GLP-1 News: New Studies, Lawsuits & Compounding What do the latest GLP-1 studies actually mean for patients? This week, Kim is joined by Maria Rising, GLP-1 advocate, creator of GLP-1 News Now, our special guest News Correspondent. After living with PCOS and surviving a stroke in her 20s, Maria became passionate about helping patients understand the science behind obesity, GLP-1 medications, and access to care. There isn't just one new GLP-1 study every week anymore. There are dozens. Maria follows the research, policy changes, and industry news so patients don't have to. Together, Kim and Maria break down the latest headlines and explain what they actually mean for people living with obesity and metabolic disease. In this episode: - Maria's journey with PCOS, stroke, and GLP-1 treatment - The latest GLP-1 studies and research - Compounding updates and current lawsuits - What new research means for patients - Obesity, metabolic health, and access to care - How to separate headlines from evidence For ongoing GLP-1 news, research, and access updates, be sure to subscribe to Maria's Substack and TikTok. TikTok: https://www.tiktok.com/@tirzepatidetales Substack: https://glp1newsnow.substack.com The Plus SideZ Podcast is an educational podcast focused on obesity, metabolic health, and GLP-1 medications. This episode is for informational purposes only and is not medical advice. Always talk with your healthcare provider about questions regarding your treatment. Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Resources for the Community: ___________________________________________________________________ Linktree Our Favorite Things Join our GLP-1 Support Group ______________________________________________________________________ "Both Our Advice and that of our Guest Expertalong with their insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you." A Note Before You Listen: Our guest uses the term fat rather than obesity because that's the language of her community. At The Plus SideZ, we believe listening to different perspectives helps us better understand one another. If this language doesn't feel right for you, it's okay to honor that boundary and skip this episode. The GLP-1 and body positivity communities are often portrayed as being at odds. But do they share more common ground than we realize? In this episode, we sit down with Tigress Osborn, Executive Director of the National Association to Advance Fat Acceptance (NAAFA), to better understand the fat acceptance movement, the language it uses, and how it views obesity, GLP-1 medications, healthcare, body image, and weight stigma. Together, we explore where these communities differ, where they overlap, and whether listening to one another can lead to greater understanding. Whether you agree or disagree, our goal isn't to debate or sway. It's to listen, learn, consider a different perspective, and better understand one another. Follow Tigress Instagram - https://www.instagram.com/iofthetigress/?hl=en Here book - https://www.amazon.com/Weight-Wisdom-Reflections-Decades-Liberation-ebook/dp/B0DRZ9R6XN Learn more about Tigress Osborn and NAAFA: • NAAFA: National Association to Advance Fat Acceptance (NAAFA) • Socials: @naafaofficial ______________________________________________________________________ Join this channel to get access to perks: / @theplussidez ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Resources for the Community: ___________________________________________________________________ Linktree Our Favorite Things Need help appealing your GLP-1 dials? www.FindHonestCare.com/Kim Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________ * Both Our Advice and that of our Guest Experts along with their insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you. This is a rapid fire FAQ about the Medicare Bridge Program and coverage of with an obesity Doctor. Dr. Michael Albert an Obesity Medicine Specialist joins the conversation to answer common questions about Medicare coverage and the new Medicare Bridge Program, including: • Who qualifies • How the program works • How to apply • Options if you don't qualify He also discusses: • Weight loss with GLP-1s in older adults • Protecting muscle mass and prioritizing protein • Side effects to watch for • What to advocate for with your doctor Whether you're on Medicare, approaching eligibility, or helping a loved one navigate obesity treatment, this episode offers practical advice, patient perspectives, and expert guidance. Follow Dr. Michael Albert Instagram and TikTok: @michaelalbertmd Website: MichaelAlbertMD.com ______________________________________________________________________ Join this channel to get access to perks: / @theplussidez ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Resources for the Community: ___________________________________________________________________ Linktree Our Favorite Things Need help appealing your GLP-1 dials? www.FindHonestCare.com/Kim Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________ "Both Our Advice and our Guest Expert insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you." How GLP-1s Broke Diet Culture For decades, we believed weight gain and weight loss were mostly about willpower, calories, and exercise. Today, we’re learning there’s much more happening beneath the surface. The biology that drives hunger, metabolism, weight gain, and long-term health is far more complex than we once understood. In this episode, Dr. Chiadi Ndumele , preventive cardiologist at Johns Hopkins Medicine and a leader with the American Heart Association, explains why GLP-1 medications work, how weight, metabolism, and chronic disease are connected, and why the first-ever Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline represents a major shift in how we understand and treat weight-related disease. You’ll also hear a powerful patient story that shows why this new understanding is giving hope to millions. In this episode: Why GLP-1 medications work when diets often don’t. What really drives weight gain, weight loss, and long-term weight management. How metabolism, hormones, genetics, and overall health work together. Why understanding your body can help you advocate for the quality care you deserve. Guest Dr. Chiadi Ndumele Preventive Cardiologist, Johns Hopkins Medicine Chair, 2026 American Heart Association/American College of Cardiology Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline Resources American Heart Association: New Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline https://www.heart.org/en/news/2026/06/09/new-ckm-guideline-urges-early-weight-talks-to-prevent-health-risks Professional Heart Daily: 2026 Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome https://professional.heart.org/en/science-news/2026-guideline-for-the-prevention-detection-evaluation-and-management-of-ckm-syndrome American Heart Association News Release: First-Ever Clinical Practice Guideline for Cardiovascular-Kidney-Metabolic Syndrome https://newsroom.heart.org/news/first-ever-guideline-on-cardiovascular-kidney-metabolic-syndrome-issued ______________________________________________________________________ Join this channel to get access to perks: / @theplussidez ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Resources for the Community: ___________________________________________________________________ Linktree Our Favorite Things Need help appealing your GLP-1 dials? www.FindHonestCare.com/Kim Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________ While Kim takes time away following the loss of her sister, we're revisiting some of our most impactful conversations from Season 1. Thank you for supporting The Plus SideZ Podcast and this community during this time. Why do GLP-1 medications work when years of dieting and exercise often don't? In this episode, obesity medicine physician Dr. Matea Rentea explains why obesity is more than willpower. Through expert insight and a powerful patient story, we explore the science behind obesity, metabolism, hormones, and why "eat less, move more" often isn't enough. In this episode: • Why diets fail for many people living with obesity • How hormones and metabolism affect weight loss • Why GLP-1 medications work differently • The role of exercise, mental health, and weight stigma • Real patient experiences alongside evidence-based medicine Whether you're new to GLP-1s or have been with us since Season 1, this conversation remains one of our most requested episodes. This episode was originally recorded in Season 1. Medical information reflects what was known at the time of recording. Always talk with your healthcare provider before making medical decisions. Follow Dr. Rentea https://www.renteaclinic.com/ ______________________________________________________________________ Join this channel to get access to perks: / @theplussidez ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Resources for the Community: ___________________________________________________________________ Linktree Our Favorite Things Need help appealing your GLP-1 dials? www.FindHonestCare.com/Kim Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________ Can GLP-1s Affect Food Noise, Alcohol, and Addiction? ** While Kim takes time away following the passing of her sister, we're revisiting some of our most impactful conversations. Thank you for your kindness, patience, and continued support of The Plus SideZ Podcast. We're sharing this episode because it's more relevant today than when it first aired. Since then, research has expanded interest in whether GLP-1 medications may affect more than weight loss, including food noise, alcohol cravings, and other compulsive behaviors. While the science continues to evolve, so does the conversation. Licensed therapist and addiction treatment leader Dr. Joy Bracey joins community member Brenda, who shares how Mounjaro changed her relationship with food, alcohol, and smoking. Together, they discuss the brain, behavior, and why this emerging area of research is drawing growing interest. **In this episode:** • Brenda's journey with obesity, binge eating, alcohol, smoking, and Mounjaro • Food noise, binge eating, and emotional eating • GLP-1 medications, dopamine, and the brain • Alcohol cravings and addictive behaviors • Mental health, self-love, and healing • Why researchers are studying GLP-1 medications beyond weight loss *Originally recorded during Season 1. This episode reflects the information available at the time of recording. Research and clinical guidance have continued to evolve. It is intended for education and discussion only and is not medical advice. Always consult your healthcare provider regarding your individual care.* ______________________________________________________________________ Join this channel to get access to perks: / @theplussidez ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Resources for the Community: ___________________________________________________________________ Linktree Our Favorite Things Need help appealing your GLP-1 dials? www.FindHonestCare.com/Kim Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________ Will Medicare finally expand access to GLP-1 medications for obesity? How do you qualify? In this episode, Kim and Kat are joined by community co-host Deb Cooperman and DeeDee, a 70-year-old GLP-1 patient, to discuss Medicare coverage, weight loss, maintenance, and life on GLP-1s after 60. Deb shares her experience paying cash for treatment while hoping to qualify for the new Medicare Bridge Program. DeeDee discusses maintaining her weight loss after losing access to medication, moving to compounded treatment, and growing up in a generation shaped by diet culture. Topics include: • GLP-1 medications after 60 • Weight loss and maintenance • Medicare coverage and affordability • Diet culture and obesity • Long-term patient tips and lessons learned • Access to obesity treatment Obesity medicine specialist Dr. Michael Albert joins the conversation to answer common questions about Medicare coverage and the new Medicare Bridge Program, including: • Who qualifies • How the program works • How to apply • Options if you don't qualify He also discusses: • Weight loss with GLP-1s in older adults • Protecting muscle mass and prioritizing protein • Side effects to watch for • What to advocate for with your doctor Whether you're on Medicare, approaching eligibility, or helping a loved one navigate obesity treatment, this episode offers practical advice, patient perspectives, and expert guidance. Follow Guests Follow Deb https://www.instagram.com/thedebcooperman https://www.instagram.com/thedebcooperman Follow Dee Dee TikTok https://www.tiktok.com/@deesback Dr. Michael Albert Instagram and TikTok: @michaelalbertmd Website: MichaelAlbertMD.com #GLP1 #Medicare #MedicareCoverage #ObesityMedicine #WeightLoss #HealthyAging #Zepbound #Wegovy ________________________________________________________________________ Join this channel to get access to perks: / @theplussidez ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Resources for the Community: ___________________________________________________________________ Linktree Our Favorite Things Need help appealing your GLP-1 denials? www.FindHonestCare.com/Kim Ro - Telehealth for GLP1 Weight Management GLP-1 Stall? Why Your Body Stops Losing Weight | Dr. Michelle Gordon Hosts Kim Carlos and Kat Carter talk with obesity medicine specialist Dr. Michelle Gordon about the biological factors behind a GLP-1 weight loss plateau. If you are on a medication like tirzepatide or semaglutide and the scale stops moving, it is driven by a complex neuroendocrine response. Dr. Gordon explains that the hypothalamus operates like a stubborn thermostat, defending a specific weight set point. When you lose weight, the brain reads the change as a threat and triggers physiological defenses. To prevent further weight loss, the body increases hunger hormones and simultaneously lowers its energy expenditure. Key topics include: The Mechanism of a Stall: A weight plateau occurs at the exact point where your declining daily energy expenditure meets your rising natural hunger signals. Menopause and Fat Oxidation: Midlife hormonal shifts cause fat oxidation to drop, which alters metabolic burn rates and shifts fat storage to the stomach. The Chronic Disease Reality: Clinical data shows that stopping a GLP-1 medication typically results in regaining about two thirds of the lost weight, proving obesity requires continuous management. Muscle Mass Preservation: Rapid weight loss from any method causes muscle loss, making strength training essential to preserve lean muscle and protect long-term functional health. Connect to Dr. Michelle Gordon: Substack : h ttps://drmichellegordon.substack.com/ Instagram: https://www.instagram.com/doctormichellegordon/ Facebook : https://www.facebook.com/drmichellegordon/ Practice Website: https://drmichellegordon.com/ LinkedIn : https://www.linkedin.com/in/drmichellegordon/ ______________________________________________________________________ Join this channel to get access to perks: / @theplussidez ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1Stories Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree for Community Resources Need help appealing a GLP-1 Insurance Denial? FindHonestCare.com/Kim Ro - Telehealth for GLP1 Weight Management The Absolute Lies You’ve Heard About GLP-1s (Ozempic Myths Debunked) [REPLAY] Are you being lied to about Ozempic, Mounjaro, and Wegovy? In this special replay episode, leading obesity medicine specialists break down the biggest GLP-1 myths taking over your feed. We are reposting this crucial conversation because it is more relevant than ever. With GLP-1 price changes and expanding access options through federal programs like the Medicare GLP-1 Bridge, understanding the real science behind these medications is essential for patient advocacy. We are sharing a few favorite replay episodes right now while Kim is away on bereavement leave following the loss of her sister. We want to deeply thank our subscribers for staying engaged and supporting the show during this time. In this episode of The Plus Sidez Podcast, Kat joins Kim to sit down with obesity medicine specialists Dr. Matea Rentea and Dr. Ali Novitzki to help listeners better understand their disease and feel empowered in their healthcare journey. The Myths We Debunk: The Muscle Loss Scare: The data behind weight loss and body composition, explaining why the medication itself is not destroying your lean mass. The Willpower Narrative: Why obesity is a genetic, chronic metabolic disease rooted in brain biology, not a failure of personal willpower. The Shot-Only Illusion: How the medication works alongside your body's natural satiety signals and gut receptors. Obesity Doctor Guidance Shared: Metabolic Protection: A practical discussion on utilizing a 10-minute fitness routine and a 100-gram protein framework to maintain lean mass and support insulin sensitivity. System Navigation: Insights on navigating insurance barriers, managing prior authorizations, and advocating for proper medical care. Mental Resilience: Tools to process unsolicited comments about your weight and protect your peace from societal judgment. Episode Topics: Why We Are Replaying This Episode: Prices, Access, and Updates The Insurance Landscape: Understanding Prior Authorizations Meet the Obesity Medicine Specialists Deconstructing the GLP-1 Muscle Loss Narrative Strategies for Protecting Your Metabolism What the Scales Do Not Show About Insulin Resistance Natural Satiety Triggers and Gut Receptors Recognizing Obesity as a Biological Chronic Disease Addressing Weight Stigma and External Commentary Subscribe to The Plus Sidez Podcast for science-backed episodes breaking down metabolic health, body recomposition, and the truth about weight loss. Search Tags GLP1 lies debunked, Ozempic myths, Mounjaro weight loss journey, Wegovy truth, Zepbound body recomposition, insulin sensitivity hacks, natural GLP1 boosters, treating obesity metabolic disease, plus sidez podcast, dr matea rentea, dr ali novitzki _________________________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree for Community Resources Need help appealing your GLP-1 insurance denials? Try findhonestcare.com/kim Ro - T elehealth for GLP1 Weight Management _________________________________________________________________________ GLP-1 Over 60: Why This Feels Different Now Part 2 ***Note: Kim had some sound issues, so we appreciate your patience and grace with her audio this episode. What does it mean to start GLP-1 treatment later in life… after years of trying to make weight loss work? In this episode, Kim and Kat talk with Dr. Lindsey Ogle, an obesity specialist, and Deb Cooperman, an obesity care advocate and content creator, about starting GLP-1 treatment in your 60s and why the experience can feel different this time around. As more adults over 60 explore GLP-1 medications, Deb shares her story openly, from decades of diet culture and early messaging about weight to grief, food noise, and navigating obesity treatment later in life. And we also discuss the upcoming coverage of GLP-1s for obesity on Medicare (and maybe Medicaid) in July 2026. Dr. Ogle helps connect those experiences to the science, including expectations, side effects, protein, muscle preservation, and what support can look like as we age. What we cover: - GLP-1 weight loss over 60 - Food noise and obesity beyond willpower - Diet culture and lifelong messaging around weight - Grief, stress, and emotional eating - Protein, muscle preservation, and aging on GLP-1s - Side effects and realistic expectations Follow Deb Follow Dr. Ogle _________________________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree for Community Resources Need help appealing your GLP-1 insurance denials? Try findhonestcare.com/kim Ro - Telehealth for GLP1 Weight Management and GLP-1 _________________________________________________________________________ *** Note: Kim had some sound issues, so we appreciate your patience and grace with her audio this episode. What does it mean to start GLP-1 treatment later in life… after years of trying to make weight loss work? In this episode, Kim and Kat talk with Dr. Lindsey Ogle, an obesity specialist, and Deb Cooperman, an obesity care advocate and content creator, about starting GLP-1 treatment in your 60s and why the experience can feel different this time around. As more adults over 60 explore GLP-1 medications, Deb shares her story openly, from decades of diet culture and early messaging about weight to grief, food noise, and navigating obesity treatment later in life. And we also discuss the upcoming coverage of GLP-1s for obesity on Medicare (and maybe Medicaid) in July 2026. Dr. Ogle helps connect those experiences to the science, including expectations, side effects, protein, muscle preservation, and what support can look like as we age. What we cover: - GLP-1 weight loss over 60 - Food noise and obesity beyond willpower - Diet culture and lifelong messaging around weight - Grief, stress, and emotional eating - Protein, muscle preservation, and aging on GLP-1s - Side effects and realistic expectations Follow Deb Follow Dr. Ogle _________________________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree for Community Resources Need help appealing GLP-1 insurance denials? findhonestcare.com/kim Ro - Telehealth for GLP1 Weight Management Ro.Co/PlusSideZ _________________________________________________________________________ What if millions of women with PCOS were misunderstood for years because the condition was treated mainly as a reproductive disorder instead of a metabolic disease tied to insulin resistance, obesity, hormones, and fertility? In this episode of The Plus SideZ Podcast, Dr. Melanie Cree, a pediatric endocrinologist, obesity researcher, and PCOS/PMOS expert, explains the recent global consensus to rename PCOS to PMOS, or Polyendocrine Metabolic Ovarian Syndrome, to better reflect the condition’s metabolic and hormonal impact. Dr. Cree breaks down how delayed diagnosis and outdated understanding may have prevented many patients from getting earlier metabolic treatment and intervention. We discuss: Why so many women with PCOS were misunderstood or dismissed The connection between PCOS, PMOS, insulin resistance, obesity, and fertility Why weight gain is not just about willpower Adolescent PCOS and why early intervention matters GLP-1 medications like semaglutide for PCOS/PMOS Emerging research focused on ovulation, fertility, and metabolic health How hormones, appetite, and metabolism are connected Why the PMOS name change could improve diagnosis and treatment Dr. Cree also shares information about her ongoing research and studies exploring how GLP-1 medications may help improve metabolic and reproductive health in people with PCOS/PMOS. Learn more about studies https://medschool.cuanschutz.edu/pediatrics/sections/endocrinology/endocrinology-research/cree-lab/Cree-Melanie-UCD4665?utm_source=chatgpt.com _________________________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree for Community Resources Need help appealing GLP-1 Insurance Denials? Try Honest Care ! www.findhonestcare.com/Kim Ro - Telehealth for GLP1 Weight Management _________________________________________________________________________ This week, we’re revisiting one of the most powerful conversations in Plus SideZ Podcast history with Rosie O'Donnell. As Kim takes time away following the loss of her sister, we’re sharing a few meaningful “greatest hits” episodes that continue to resonate deeply with listeners. Thank you for continuing to support, download, watch, and share the podcast during this difficult time. This community means more than you know. In this replay, Rosie opens up about: - Lifelong struggles with weight and obesity - How the media treated her body over the years - Bariatric surgery and her experience after surgery - Emotional eating, shame, and public scrutiny - What it feels like to navigate weight and health over 60 - Her experience with GLP-1 medications and changing obesity treatment As conversations around GLP-1 medications continue to grow, especially with major Medicare coverage changes expected to expand in July 2026, this episode feels more relevant than ever. For many adults over 60, questions about obesity treatment, metabolism, bariatric surgery, and whether GLP-1s can still work after decades of dieting are finally entering the mainstream. This episode goes beyond headlines and before-and-after stories. It’s an honest conversation about biology, stigma, survival, and what happens when people living with obesity are finally heard with compassion instead of judgment. If you’ve ever wondered: - Do GLP-1 medications work differently over 60? - Can GLP-1s help after bariatric surgery? - Why does weight loss feel harder with age? - How much of obesity is biology versus willpower? …this conversation is for you. Listen now wherever you get your podcasts and subscribe to The Plus SideZ Podcast for more conversations that validate lived experience with science, honesty, and empathy. _________________________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

Linktree for Community Resources Need help appealing your GLP-1 insurance denial ? Try Honest Care! www.findhonestcare.com/Kim Ro - Telehealth for GLP1 Weight Management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55 _________________________________________________________________________ GLP-1 Stopped Working? What’s Really Happening with Dr. Spencer Nadolsky, While Kim is on bereavement leave, we’re replaying one of our most important conversations. Thank you for continuing to listen and support the show during this time. We’re bringing this episode back because our audience keeps growing, and many of you may be in a different stage of your journey now. Maybe you’ve hit a plateau, gone months without losing weight, or started wondering, “Is my GLP-1 even working anymore?” In this replay, we’re joined by Dr. Spencer Nadolsky, obesity specialist and founder of Vineyard, to break down what’s really happening when progress slows or stops. In this episode, we cover: Why your GLP-1 may feel like it “stopped working” and what’s actually happening The truth about plateaus, stalls, and going months without weight loss Why food noise can come back and what that means How dose, metabolic adaptation, and expectations play into progress What to know about weight regain and whether this is a “forever” medication How to think about goal weight and long-term strategy The role of exercise and metabolism as your body changes The emotional side, including feeling flat or disconnected _________________________________________________________________________ Join this channel to get access to perks: https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join _________________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram